Just as with the first major tenant to move into The Assembly, there’s been no public announcement of a newcomer, in a move expected not to come until next year.
But public filings and a lease reported to the Pittsburgh Business Times reveals that BioHaven Pharmaceutical Holding Co. Ltd. (NYSE: BHVN), a New Haven-based life sciences firm that describes itself as a “biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments,” has taken a lease for nearly 36,500 square feet at The Assembly.
Subscription Needed
